These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 8017164)
21. Low colonic glutathione detoxification capacity in patients at risk for colon cancer. Grubben MJ; van den Braak CC; Nagengast FM; Peters WH Eur J Clin Invest; 2006 Mar; 36(3):188-92. PubMed ID: 16506964 [TBL] [Abstract][Full Text] [Related]
22. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Kumar H; Heer K; Lee PW; Duthie GS; MacDonald AW; Greenman J; Kerin MJ; Monson JR Clin Cancer Res; 1998 May; 4(5):1279-85. PubMed ID: 9607588 [TBL] [Abstract][Full Text] [Related]
23. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Engelhardt M; Drullinsky P; Guillem J; Moore MA Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582 [TBL] [Abstract][Full Text] [Related]
24. [Fasting blood gastrin levels in colon adenomas and colorectal carcinomas]. Kaufmann HP; Ottenjann R Z Gastroenterol; 1991 Oct; 29(10):527-8. PubMed ID: 1781190 [TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps. Ulrich CM; Bigler J; Sparks R; Whitton J; Sibert JG; Goode EL; Yasui Y; Potter JD Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):889-93. PubMed ID: 15159324 [TBL] [Abstract][Full Text] [Related]
26. [Endoscopic polypectomy in benign adenoma and in early colo-rectal lesions]. Brini C; Pietropaolo V; Bogliolo G; Lande A; Gerardi A; Pontone P G Chir; 1999 Oct; 20(10):436-9. PubMed ID: 10555415 [TBL] [Abstract][Full Text] [Related]
27. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma. Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568 [TBL] [Abstract][Full Text] [Related]
28. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage. Sebzda T; Saleh Y; Gburek J; Warwas M; Andrzejak R; Siewinski M; Rudnicki J J Exp Ther Oncol; 2006; 5(3):223-9. PubMed ID: 16528972 [TBL] [Abstract][Full Text] [Related]
29. NuMA: evaluation of a new biomarker for the detection of low stage colorectal cancer. Briggman J; Genduso R; Camara C; Healy B; Shapiro K; Roos R; Merrifield S; Lifter J; Wu YJ; Elder E; Talamonti M Anticancer Res; 1999; 19(4A):2411-4. PubMed ID: 10470167 [TBL] [Abstract][Full Text] [Related]
30. Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study. Potter JD; Bostick RM; Grandits GA; Fosdick L; Elmer P; Wood J; Grambsch P; Louis TA Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):779-84. PubMed ID: 8896888 [TBL] [Abstract][Full Text] [Related]
31. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125 [TBL] [Abstract][Full Text] [Related]
32. Telomerase activity and p53 gene mutation in familial polyposis coli. Ikeguchi M; Makino M; Kaibara N Anticancer Res; 2000; 20(5C):3833-7. PubMed ID: 11268463 [TBL] [Abstract][Full Text] [Related]
33. Colorectal carcinoma associated with serrated adenoma--prevalence, histological features, and prognosis. Mäkinen MJ; George SM; Jernvall P; Mäkelä J; Vihko P; Karttunen TJ J Pathol; 2001 Mar; 193(3):286-94. PubMed ID: 11241406 [TBL] [Abstract][Full Text] [Related]
34. Does high body fatness increase the risk of presence and growth of colorectal adenomas followed up in situ for 3 years? Almendingen K; Hofstad B; Vatn MH Am J Gastroenterol; 2001 Jul; 96(7):2238-46. PubMed ID: 11467659 [TBL] [Abstract][Full Text] [Related]
35. Inflammation-related gene polymorphisms and colorectal adenoma. Gunter MJ; Canzian F; Landi S; Chanock SJ; Sinha R; Rothman N Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1126-31. PubMed ID: 16775170 [TBL] [Abstract][Full Text] [Related]
36. Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Chung YW; Han DS; Park YK; Son BK; Paik CH; Lee HL; Jeon YC; Sohn JH Dig Liver Dis; 2006 Sep; 38(9):668-72. PubMed ID: 16790371 [TBL] [Abstract][Full Text] [Related]
37. Calcium chemoprevention in colorectal cancer. Duris I; Hruby D; Pekarkova B; Huorka M; Cernakova E; Bezayova T; Ondrejka P Hepatogastroenterology; 1996; 43(7):152-4. PubMed ID: 8682453 [TBL] [Abstract][Full Text] [Related]
38. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer. Sandler RS Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132 [TBL] [Abstract][Full Text] [Related]